Work

CPX-351 ((Cytarabine:Daunorubicin) Liposome Injection, (Vyxeos)) Does Not Prolong Qtcf Intervals, Requires No Dose Adjustment for Impaired Renal Function and Induces High Rates of Complete Remission in Acute Myeloid Leukemia

Year: 2015

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood.v126.23.2510.2510

Authors: Tara L. Lin, Laura F. Newell, Robert K. Stuart, Laura C. Michaelis, Stephen E. Rubenstein, Helen S. Pentikis, Timothy Callahan, Donna Alvarez, Lawrence D. Mayer, Arthur C. Louie

Institutions: University of Kansas Medical Center, Oregon Health & Science University, Medical University of South Carolina, Medical College of Wisconsin, Franciscan Health Indianapolis

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2536634671

Cites:

Cited by: 12

Related to: 10